Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Examines conditions under which index funds tend to outperform active options, with practical implications for portfolio building.
15,084 articlesA biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Investors are reassessing opportunities in firearm makers as policy shifts and demand cycles test the staying power o...
here thursday’s wall street mood shifts as fresh analyst notes touch on Astera Labs, Block, Digital Realty and others...
Tapestry reported solid Q2 results, led by its Coach brand, with stronger pricing and Gen Z acquisition lifting reven...
As the Iran conflict returns energy markets to sharper swings, officials closely monitor iran for signs inflation cou...
A new AI-focused ETF from Wedbush-backed manager Dan Ives is drawing attention for its blend of megacap AI leaders an...
Philip Morris International and British American Tobacco report 2025 results, revealing divergent paths in smoke-free...
December 2025 is turning market expectations on their head. This update dives into unexpected seller strategies, shif...
Investors sent shares of National Energy Services Reunited higher after news of sizable cementing contracts in the Mi...
As AI brings new pricing for memory, Micron stands at the crossroads of momentum and valuation. This guide breaks dow...
Oil shocks tied to the Iran conflict threaten U.S. growth as prices rise. Analysts say a price threshold around $110 ...
As the world leans harder on reliable, low-emission power, these nuclear energy stocks could offer compelling opportu...